Cagrilintide + Semaglutide
CagriSema combination of amylin analog with GLP-1 agonist for enhanced metabolic research. Phase 3 in development by Novo Nordisk.
>99%
Purity (HPLC)
10
Vials per Set
0
Dose Options
Select Your Dose
Each order includes 10 vials
Cagrilintide + Semaglutide × 10 vials
Code: